Assyro AI

Orange Book product · Brand (NDA)

FERRIPROX

DEFERIPRONE

Brand (NDA)NDA 212269RX CHIESI

At a glance

May 19, 2020

Approved

Brand (NDA)

Application

Not listed

TE code

6

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 19, 2020

    6 yr 2 mo ago

  2. Today

  3. Exclusivity ends · ODE-417

    Orphan-drug exclusivity (7 years)

    Apr 30, 2028

    in 1 yr 11 mo

  4. Exclusivity ends · ODE-420

    Orphan-drug exclusivity (7 years)

    Apr 30, 2028

    in 1 yr 11 mo

  5. Exclusivity ends · ODE-421

    Orphan-drug exclusivity (7 years)

    Apr 30, 2028

    in 1 yr 11 mo

  6. Patent 10780055 expires

    Listed drug product patent expiration.

    Oct 25, 2038

    in 12 yr 6 mo

  7. Patent 10940115 expires

    Listed drug product patent expiration.

    Oct 25, 2038

    in 12 yr 6 mo

  8. Patent 10940116 expires

    Listed drug product patent expiration.

    Oct 25, 2038

    in 12 yr 6 mo

  9. Patent 11357731 expires

    Listed method-of-use patent (U-3083) expiration.

    Oct 25, 2038

    in 12 yr 6 mo

  10. Patent 11458103 expires

    Listed drug product patent expiration.

    Oct 25, 2038

    in 12 yr 6 mo

  11. Patent 11723874 expires

    Listed method-of-use patent (U-3083) expiration.

    Oct 25, 2038

    in 12 yr 6 mo

Pharmaceutical detail

Active ingredient

DEFERIPRONE

Strength

1GM

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 212269

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (3)

  • ODE-417Orphan-drug exclusivity (7 years)

    Apr 30, 2028

    in 1 yr 11 mo

  • ODE-420Orphan-drug exclusivity (7 years)

    Apr 30, 2028

    in 1 yr 11 mo

  • ODE-421Orphan-drug exclusivity (7 years)

    Apr 30, 2028

    in 1 yr 11 mo

Listed patents (6)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10780055Oct 25, 2038in 12 yr 6 mo
ProductU-3083
10940115Oct 25, 2038in 12 yr 6 mo
ProductU-3083
10940116Oct 25, 2038in 12 yr 6 mo
Product
11357731Oct 25, 2038in 12 yr 6 mo
U-3083
11458103Oct 25, 2038in 12 yr 6 mo
Product
11723874Oct 25, 2038in 12 yr 6 mo
U-3083
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.